Free-cash-flow proxy increased 43.5%
Free-cash-flow proxy changed +43.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +43.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +79.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +43.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -35.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +51907 basis points from the comparable as-filed period.
Revenue changed +190.2% from the comparable as-filed period.
Research & development changed -42.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -485 basis points from the comparable as-filed period.
Stock-based compensation changed -38.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -27.5% from the comparable as-filed period.
SBC / revenue changed -5884 basis points from the comparable as-filed period.
Current assets changed -27.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed -26.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed -25.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed +37.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -570810 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +31.9% from the comparable as-filed period.
Revenue changed -78.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +31.8% from the comparable as-filed period.
Research & development changed -42.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +2508 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -32.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -46.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -29.3% from the comparable as-filed period.
SBC / revenue changed +69501 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -28.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -27.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed -27.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.